Merck

Blockbuster Vaccines of the Future
Fierce Biotech
Thu, 11/18/10 - 11:27 am
vaccines
GSK
Intercell
Diamyd Medical
Sanofi Pasteur
Merck
Paladin
Greer
Fornix
Allergy Therapeutics
Nabi
Top 15 Pharma R&D Budgets
Fierce Pharma
Thu, 11/18/10 - 08:47 am
R&D
Roche
Pfizer
Novartis
JNJ
Sanofi
GSK
Merck
Takeda
AstraZeneca
Eli Lilly
Boehringer Ingelheim
Bristol-Myers Squibb
Abbott Laboratories
Daiichi Sankyo
Astellas
Cholesterol drug could be financial boon for Merck
Yahoo/AP
Wed, 11/17/10 - 06:24 pm
Merck
cholesterol
Anacetrapib
Pfizer
Resverlogix Falls on Merck's `Huge Success' With Rival Cholesterol Drug
Bloomberg
Wed, 11/17/10 - 12:57 pm
Merck
Resverlogix
cholesterol
Merck set with India strategy; talks on for partnerships
Live Mint, India
Mon, 11/15/10 - 11:20 am
Merck
India
Merck Climbs on the Emerging Markets Bandwagon
Seeking Alpha
Sun, 11/14/10 - 12:46 pm
Merck
emerging markets
Cardiome Pharma 3Q profit surges on Merck payment
Yahoo/AP
Thu, 11/11/10 - 05:48 pm
earnings
Merck
Cardiome
Bone Drug Suits Raise Questions for Doctors, and Juries
NY Times, NY
Thu, 11/11/10 - 11:01 am
osteoporosis
Merck
lawsuits
Fosamax
Few Teenage Girls, Young Women Get HPV Vaccines
Pharmalot
Thu, 11/11/10 - 09:02 am
HPV
vaccines
Cervarix
Gardasil
Merck
GSK
Merck Restarts Cholesterol Race Four Years After Pfizer Failure
Bloomberg
Wed, 11/10/10 - 08:19 am
Merck
Pfizer
cholesterol
CETP inhibitors
The Trouble With Pharma…
Seeking Alpha
Wed, 11/10/10 - 07:52 am
JNJ
Merck
Pfizer
Appeals Court Backs Merck Against Teva in Temodar Fight
Seeking Alpha
Wed, 11/10/10 - 07:51 am
Merck
Teva Pharmaceuticals
patents
Temodar
Merck Seeks 25% of Sales From Emerging Markets by 2013
Bloomberg
Tue, 11/9/10 - 08:05 am
Merck
emerging markets
Merck’s Gardasil Should Be Approved in Anal Cancer, FDA Says
Bloomberg
Tue, 11/2/10 - 11:12 am
Merck
Gardasil
anal cancer
Vertex Pharma reports positive results for experimental hepatitis C drug in African Americans
Yahoo/AP
Mon, 11/1/10 - 01:50 pm
hepatitis C
Vertex Pharmaceuticals
Telaprevir
Bristol-Myers Squibb
Merck
JNJ
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Seeking Alpha
Sun, 10/31/10 - 11:35 am
Teva Pharmaceuticals
Sanofi
Pfizer
Pacific Biosciences
Merck
Macrogenics
Hikma
GSK
BMP Sunstone
biotech
Baxter International
Amicus Therapeutics
Immune Design
MedImmune
7 Pharma Stocks Near 52-Week Highs
Motley Fool
Sat, 10/30/10 - 12:43 pm
JNJ
Novartis
Merck
Abbott Laboratories
AstraZeneca
Novo Nordisk
Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies
Bloomberg
Sat, 10/30/10 - 12:41 pm
Vertex Pharmaceuticals
Merck
hepatitis C
Telaprevir
Roche
Pegasys
Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control
Yahoo/BusinessWire
Sat, 10/30/10 - 12:39 pm
Merck
hepatitis C
Boceprevir
Cost Cuts Help Merck to Avert Revenue Losses
NY Times
Sat, 10/30/10 - 12:37 pm
Merck
Vioxx

Pages